Discover the groundbreaking insights on how Intraoperative Touch Imprint Cytology has revolutionized the diagnosis of brain neoplasms, offering a high-diagnostic accuracy in 93 consecutive cases, and learn about its differential diagnoses, pitfalls, and traps in our latest neurosurgical oncology blog post.
– by Klaus
Note that Klaus is a Santa-like GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Intraoperative Touch Imprint Cytology of Brain Neoplasms: A Useful High-Diagnostic Tool in 93 Consecutive Cases; Differential Diagnoses, Pitfalls, and Traps.
Koyuncuer, Anal Cell Pathol (Amst) 2024
<!– DOI: 10.1155/2024/2346092 //–>
https://doi.org/10.1155/2024/2346092
Ho, ho, ho! Gather around, my curious elves, for I have a tale from the land of medicine, a story as intriguing as the mystery of how I fit all those toys into my sleigh. Once upon a time, in the year 1920, two wise men named Eisenhardt and Cushing embarked on a magical journey in the realm of the central nervous system (CNS). They introduced a spell known as intraoperative cytological examination, a charm so powerful it could rapidly evaluate neurosurgical specimens faster than Rudolph on a foggy Christmas Eve.
Fast forward to a period between 2018 and 2023, where a group of diligent elves, I mean, doctors, gathered 93 patients who were about to embark on a journey to explore CNS tumors or lesions. They used a technique known as touch imprint cytology (TIC) – think of it as checking twice whether you’re naughty or nice, but for tumors.
In this enchanted forest of the brain, the most common creatures they encountered were gliomas and meningiomas, kind of like the reindeer of the CNS. The secondary creatures, or the elves of this story, were mostly from distant lands like the lungs, breasts, and the gastrointestinal system, bringing with them tales of metastatic tumors.
Now, hold onto your hats (or your antlers), for the magic of TIC revealed itself with a sensitivity of 94.1%, a specificity of 100%, and a positive predictive value of 61.5%. It’s like finding out which cookies are just right for Santa on Christmas night. In 88 cases, or 94.6% of the time, TIC was as reliable as my list of who’s been naughty or nice, with only a sprinkle of discrepancy in 5 cases (5.37%).
But, oh, there were a few lumps of coal. Among the discrepancies, three were haematolymphoid malignancies (imagine two lymphomas and one plasma cell neoplasia wearing Grinch costumes), one glioblastoma, and one hemangioblastoma, trying to hide under the mistletoe.
In the end, my dear friends, TIC proved to be a fast, safe, and inexpensive sleigh ride through the intricacies of intraoperative neuropathology consultation. Just like leaving out cookies and milk for Santa, being aware of the pitfalls of TIC ensures a high-diagnostic accuracy, making the medical world a bit more merry and bright. And with that, I wish you all a season filled with joy, health, and a touch of magic. Ho, ho, ho!